Fortitude Family Office LLC Acquires Shares of 1,300 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fortitude Family Office LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 1,300 shares of the exchange traded fund’s stock, valued at approximately $117,000.

Several other large investors have also recently bought and sold shares of XBI. Hartline Investment Corp increased its holdings in SPDR S&P Biotech ETF by 2.0% in the third quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock valued at $544,000 after buying an additional 106 shares in the last quarter. Signature Estate & Investment Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 5.7% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after acquiring an additional 125 shares during the period. Denver Wealth Management Inc. increased its stake in SPDR S&P Biotech ETF by 0.9% in the 3rd quarter. Denver Wealth Management Inc. now owns 14,779 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 127 shares in the last quarter. Resources Management Corp CT ADV raised its holdings in SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares during the last quarter. Finally, Trust Co. of Vermont boosted its position in SPDR S&P Biotech ETF by 4.7% during the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock worth $302,000 after purchasing an additional 138 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 0.6 %

Shares of XBI stock opened at $92.31 on Friday. The stock has a market cap of $7.04 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a fifty-two week low of $81.14 and a fifty-two week high of $105.47. The business has a fifty day simple moving average of $95.67 and a 200-day simple moving average of $97.09.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.